Tranexamic acid for control of blood loss in bilateral total knee replacement in a single stage
2011

Using Tranexamic Acid to Reduce Blood Loss in Knee Surgery

Sample size: 108 publication 10 minutes Evidence: high

Author Information

Author(s): Mandeep S Dhillon, Kamal Prabhakar Bali, Sharad Prabhakar

Primary Institution: Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh, India

Hypothesis

Administration of TEA to patients undergoing bilateral TKA in a single stage would help reduce postoperative blood loss and decrease allogenic blood transfusion requirements.

Conclusion

TEA administered in patients undergoing single stage bilateral TKA helped reduce total blood loss and decreased allogenic blood transfusion requirements.

Supporting Evidence

  • Patients receiving TEA had a significantly lower total drain output compared to controls.
  • All patients in the control group required blood transfusions, while 25 patients in the TEA group did not.
  • The postoperative hemoglobin levels were significantly lower in the control group.

Takeaway

This study shows that giving a medicine called tranexamic acid can help patients who have knee surgery lose less blood and need fewer blood transfusions.

Methodology

A case control study comparing 52 patients receiving TEA with 56 matched controls who did not receive TEA.

Potential Biases

The case control design may introduce bias as it did not allow for randomization.

Limitations

The study did not measure intraoperative blood loss, which could affect total blood loss calculations.

Participant Demographics

Patients with primary osteoarthritis of the knee undergoing simultaneous bilateral TKA.

Statistical Information

P-Value

0.000

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.4103/0019-5413.77135

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication